A few days ago, Vaxart (NASDAQ: VXRT) was arguably the best-performing coronavirus vaccine stock of all time. If you had invested $5,000 in the stock last year, that principal would have grown into a stunning $205,000 by Feb. 2. But not even 24 hours later, Vaxart stock took a deRead MoreMarketsMarkets Feed